Login
Home
Charts
Search
Watchlist
Products

Panacea Biotec Ltd

PANACEABIO·NSE
₹381.75-0.24%Wed, 23 Sept '26 15:57
Industry:Pharma - Others
Indices:

Panacea Biotec Ltd

PANACEABIO
NSE
₹381.75
-0.24%
|Wed, 23 Sept '26 15:57
SOICxStockScans Reports
Industry
Pharma - Others
Indices
View
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
Financials
Documents
Shareholdings
Corporate Actions
Segments
Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Peer Comparison
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹2,343Cr
Close
Close Price
₹382.55
Industry
Industry
Pharma - Others
PE
Price To Earnings
—
PS
Price To Sales
3.48
Revenue
Revenue
₹673Cr
Rev Gr TTM
Revenue Growth TTM
10.26%
PAT Gr TTM
PAT Growth TTM
-180.22%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
143151136116147163133167141165167200
Growth YoY
Revenue Growth YoY%
36.030.65.8-10.43.08.6-2.944.0-4.21.025.819.7
Expenses
ExpensesCr
147151143130140156159168159153164194
Operating Profit
Operating ProfitCr
-40-6-1478-27-1-181236
OPM
OPM%
-2.5-0.1-4.4-12.14.84.9-20.3-0.7-12.67.11.52.8
Other Income
Other IncomeCr
681477636179557
Interest Expense
Interest ExpenseCr
111111112211
Depreciation
DepreciationCr
999999888888
PBT
PBTCr
-8-2-2-175407-196-14
Tax
TaxCr
110-10023-5301
PAT
PATCr
-8-2-2-1654-24-144-12
Growth YoY
PAT Growth YoY%
-152.8-111.484.3-244.6156.8301.80.0124.9-397.4-12.449.8-44.4
NPM
NPM%
-5.8-1.5-1.5-13.73.22.7-1.52.4-9.92.4-0.61.1
EPS
EPS₹
-1.4-0.4-0.2-2.60.80.7-0.30.7-2.30.70.10.4
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
143151136116147163133167141165167200
Growth YoY
Revenue Growth YoY%
36.030.65.8-10.43.08.6-2.944.0-4.21.025.819.7
Expenses
ExpensesCr
147151143130140156159168159153164194
Operating Profit
Operating ProfitCr
-40-6-1478-27-1-181236
OPM
OPM%
-2.5-0.1-4.4-12.14.84.9-20.3-0.7-12.67.11.52.8
Other Income
Other IncomeCr
681477636179557
Interest Expense
Interest ExpenseCr
111111112211
Depreciation
DepreciationCr
999999888888
PBT
PBTCr
-8-2-2-175407-196-14
Tax
TaxCr
110-10023-5301
PAT
PATCr
-8-2-2-1654-24-144-12
Growth YoY
PAT Growth YoY%
-152.8-111.484.3-244.6156.8301.80.0124.9-397.4-12.449.8-44.4
NPM
NPM%
-5.8-1.5-1.5-13.73.22.7-1.52.4-9.92.4-0.61.1
EPS
EPS₹
-1.4-0.4-0.2-2.60.80.7-0.30.7-2.30.70.10.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
653544593457544625661460559559640673
Growth
Revenue Growth%
-5.0-16.79.0-23.019.114.85.8-30.421.60.014.410.3
Expenses
ExpensesCr
541482508588513548674558579585644670
Operating Profit
Operating ProfitCr
1126285-1313177-13-98-20-26-52
OPM
OPM%
17.111.514.3-28.75.812.3-2.0-21.3-3.6-4.6-0.70.3
Other Income
Other IncomeCr
7055833915101,68715462573626
Interest Expense
Interest ExpenseCr
12710110110517418518144466
Depreciation
DepreciationCr
736859544346443937353333
PBT
PBTCr
-19-52-6649-171-1441,449131-8-7-10
Tax
TaxCr
2-1110817237147310-1
PAT
PATCr
-21-41-7641-188-1461,078-34-2-9-7-9
Growth
PAT Growth%
79.7-96.2-85.8153.8-559.222.2837.6-103.195.5-479.317.9-180.2
NPM
NPM%
-3.2-7.5-12.89.0-34.5-23.4163.1-7.3-0.3-1.6-1.1-1.3
EPS
EPS₹
-2.7-6.1-11.45.6-29.1-24.1176.0-5.4-0.2-1.4-0.9-1.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
653544593457544625661460559559640673
Growth
Revenue Growth%
-5.0-16.79.0-23.019.114.85.8-30.421.60.014.410.3
Expenses
ExpensesCr
541482508588513548674558579585644670
Operating Profit
Operating ProfitCr
1126285-1313177-13-98-20-26-52
OPM
OPM%
17.111.514.3-28.75.812.3-2.0-21.3-3.6-4.6-0.70.3
Other Income
Other IncomeCr
7055833915101,68715462573626
Interest Expense
Interest ExpenseCr
12710110110517418518144466
Depreciation
DepreciationCr
736859544346443937353333
PBT
PBTCr
-19-52-6649-171-1441,449131-8-7-10
Tax
TaxCr
2-1110817237147310-1
PAT
PATCr
-21-41-7641-188-1461,078-34-2-9-7-9
Growth
PAT Growth%
79.7-96.2-85.8153.8-559.222.2837.6-103.195.5-479.317.9-180.2
NPM
NPM%
-3.2-7.5-12.89.0-34.5-23.4163.1-7.3-0.3-1.6-1.1-1.3
EPS
EPS₹
-2.7-6.1-11.45.6-29.1-24.1176.0-5.4-0.2-1.4-0.9-1.2

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
66666666666
Reserves
ReservesCr
426340293335139-256849816814807807
Current Liabilities
Current LiabilitiesCr
475588691938455449776330309367349
Non Current Liabilities
Non Current LiabilitiesCr
93084661190739960109101949285
Total Liabilities
Total LiabilitiesCr
1,8541,8001,6081,3761,3901,1781,7591,2711,2411,2901,262
Current Assets
Current AssetsCr
549533560508683511951562485576513
Non Current Assets
Non Current AssetsCr
1,3061,2671,047868707667808709755713749
Total Assets
Total AssetsCr
1,8541,8001,6081,3761,3901,1781,7591,2711,2411,2901,262
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
66666666666
Reserves
ReservesCr
426340293335139-256849816814807807
Current Liabilities
Current LiabilitiesCr
475588691938455449776330309367349
Non Current Liabilities
Non Current LiabilitiesCr
93084661190739960109101949285
Total Liabilities
Total LiabilitiesCr
1,8541,8001,6081,3761,3901,1781,7591,2711,2411,2901,262
Current Assets
Current AssetsCr
549533560508683511951562485576513
Non Current Assets
Non Current AssetsCr
1,3061,2671,047868707667808709755713749
Total Assets
Total AssetsCr
1,8541,8001,6081,3761,3901,1781,7591,2711,2411,2901,262

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
91131118105-30107-108-4220-2717
Investing Cash Flow
Investing Cash FlowCr
16-2655-5-35-481,2834301065-41
Financing Cash Flow
Financing Cash FlowCr
-117-107-164-10191-47-1,176-18-3-3-1
Net Cash Flow
Net Cash FlowCr
-10-29-22612-2-10735-25
Free Cash Flow
Free Cash FlowCr
85107103100-2189-119-424-71-77-37
CFO To PAT
CFO To PAT%
-435.0-319.5-155.3256.216.2-73.0-10.11,251.96.6313.9-233.1
CFO To EBITDA
CFO To EBITDA%
81.2209.3139.6-79.9-97.2139.3821.4431.30.5105.6-358.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
91131118105-30107-108-4220-2717
Investing Cash Flow
Investing Cash FlowCr
16-2655-5-35-481,2834301065-41
Financing Cash Flow
Financing Cash FlowCr
-117-107-164-10191-47-1,176-18-3-3-1
Net Cash Flow
Net Cash FlowCr
-10-29-22612-2-10735-25
Free Cash Flow
Free Cash FlowCr
85107103100-2189-119-424-71-77-37
CFO To PAT
CFO To PAT%
-435.0-319.5-155.3256.216.2-73.0-10.11,251.96.6313.9-233.1
CFO To EBITDA
CFO To EBITDA%
81.2209.3139.6-79.9-97.2139.3821.4431.30.5105.6-358.2

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5689841,6361,2146711,0879086647432,6991,8142,343
Price To Earnings
Price To Earnings
32.20.8
Price To Sales
Price To Sales
0.91.82.82.71.21.71.41.41.34.82.83.5
Price To Book
Price To Book
-20.92.85.53.64.6-4.31.10.80.93.32.22.9
EV To EBITDA
EV To EBITDA
14.430.027.8-9.938.223.1-27.2-4.7-31.1-100.9-380.51,029.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
57.758.254.643.156.951.242.724.137.843.541.341.3
OPM
OPM%
17.111.514.3-28.75.812.3-2.0-21.3-3.6-4.6-0.70.3
NPM
NPM%
-3.2-7.5-12.89.0-34.5-23.4163.1-7.3-0.3-1.6-1.1-1.3
ROCE
ROCE%
7.33.93.333.60.47.2183.32.00.6-0.5-0.2-0.2
ROE
ROE%
-4.8-11.8-25.412.0-129.658.4126.1-4.1-0.2-1.1-0.9-0.9
ROA
ROA%
-1.1-2.3-4.73.0-13.5-12.461.3-2.6-0.1-0.7-0.6-0.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5689841,6361,2146711,0879086647432,6991,8142,343
Price To Earnings
Price To Earnings
32.20.8
Price To Sales
Price To Sales
0.91.82.82.71.21.71.41.41.34.82.83.5
Price To Book
Price To Book
-20.92.85.53.64.6-4.31.10.80.93.32.22.9
EV To EBITDA
EV To EBITDA
14.430.027.8-9.938.223.1-27.2-4.7-31.1-100.9-380.51,029.5
Profitability Ratios
Profitability Ratios
GPM
GPM%
57.758.254.643.156.951.242.724.137.843.541.341.3
OPM
OPM%
17.111.514.3-28.75.812.3-2.0-21.3-3.6-4.6-0.70.3
NPM
NPM%
-3.2-7.5-12.89.0-34.5-23.4163.1-7.3-0.3-1.6-1.1-1.3
ROCE
ROCE%
7.33.93.333.60.47.2183.32.00.6-0.5-0.2-0.2
ROE
ROE%
-4.8-11.8-25.412.0-129.658.4126.1-4.1-0.2-1.1-0.9-0.9
ROA
ROA%
-1.1-2.3-4.73.0-13.5-12.461.3-2.6-0.1-0.7-0.6-0.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios

Documents — Panacea Biotec Ltd

  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/4jmw9u0nibbp56kagnd7vurz.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/7m294q7091jfegl5hdtcey6u.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/ymaypbylstfkbexxgv6ufca4.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/234uwclwjppzxtzjyov51xjt.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/ff45hbnpe9xfyardbelc0q0o.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/yuc0r37rm4t9nfa4sy9daxuv.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/015dpw2tfmc4rst47jjb3jb0.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/ocnbjwhtsq5w29bdokoj7hav.pdf
  • Q1 FY2022 Investor Presentation (Jun 2021, PDF): https://www.stockscans.in/document/0kc8mjv3ftqrhxsc271q0hru.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/6a1gvfqi0n2psa8lej2qm8pp.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/0tuhwz0rtaf9hj51gksugpqg.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/h9zej684v6hmq6jay0geix8b.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/qtv7taqaev3x2tx85l7mrb96.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/py2oeqplemcq6ni184l58wqa.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/lk4hjkv69p3b2dfivxz5f7co.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/d3htj7fyvywikw7uul9fofnz.pdf

Simplify stock analysis with powerful tools and clear insights for confident, data-driven decisions.

support@stockscans.in
© StockScans by SOIC Technologies Pvt Ltd
349 A, Lodhi Road, Punjabi Bazar, New DelhiData provided by CMOTS Internet Technologies